Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-24

Clinical Trial Update: Study to Monitor the Effects of Androgen Suppression Treatment on the Heart [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether androgen suppression therapy for prostate cancer affects heart health has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Prostate Cancer | Phase 4 | Status: COMPLETED